MATERIAL SAFETY DATA SHEET: Folligen Spray Water, sodium laureth sulfate, hydrolyzed soy protein, cocamidopropyl betain, NaC14-16 olefin sulfonate, PEG-3, phenoxyethanol, polyquaternium-7, cationic guar gum, butylene glycol, fragrance (lavender & chamomile), lauramide MEA, dl-panthenol, cupric chloride, leucine, vitamin E TPGS (tocophersolan), polysorbate 80, extracts of the following (calendula officinalis flower, hydrastis canadensis (golden seal) root, humulus lupulus (hops), equisetum arvense (horsetail), matricaria (chamomile), prunus serotina (wild cherry) and lawsonia inermis (henna) MATERIAL SAFETY DATA SHEET: Folligen Shampoo Folligen Therapy Conditioner: Water, hydrolyzed soy protein, squalane, olive oil, PEG100 stearate, behentrimonium methosulfate & cetearyl alcohol, cetyl alcohol, carthamus tinctorius seed (safflower) oil, phenoxyethanol, cetrimonium chloride, dl-panthenol, polyquaternium-7, glycerin, cationic guar gum, butylene glycol, serenoa serrulata fruit extract, polysorbate 20, fragrance (Aloe), allantoin, leucine, cupric chloride, vitamin E TPGS (tocophersolan), aloe barbadensis (aloe vera) powder, extracts of the following lawsonia inermis (henna), (calendula officinalis flower, hydrastis canadensis (golden seal) root, humulus lupulus (hops), equisetum arvense (horsetail), matricaria (chamomile) and prunus serotina (wild cherry) bark) *NOTE: Hydrolyzed soy protein used in this product is MATERIAL SAFETY DATA SHEET: Folligen Conditioner Emu Oil-S Lipid Replenisher for Hair: Emu oil (distilled and refined), serenoa serrulata fruit extract, ubiquinone (CoQ-10), vitamin E (as d-alpha tocopherol plus mixed tocopherols: d-beta, d-delta and d-gamma tocopherol), xanthophyll (Lutein)
Materials H-His(Trt)-OMeHCl, H-Lys(Boc)-OMeHCl, H-Lys-OMe2HCl, ((1H-Benzo[d][1,2,3]triazol-1-yl)oxy)tri(pyrrolidine-1-yl)phosphonium hexafluorophosphate(V) (PYBOP), 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU), 1-hydroxy benzotriazole hydrate (HOBT), GHK and 4-carboxyphenyl boric acid were obtained from Bide Pharmatech Ltd (Shanghai, China)
T2D is a chronic illness requiring continuing care to prevent long-term and acute complications
Securities and Exchange Commission
2nd ed., Piscataway, NJ:Wiley (IEEE Press Series on Power Eng)
